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Background: Typically, metal-based radiopharmaceuticals are synthesized in aqueous
solutions with no or low ethanol content. Labeling yields are defined by temperature,
period of labeling, amount of precursor, pH etc. As recently observed, radiolabeling
yields (RCY) seem to increase in the presence of non-aqueous solvents. Consequently,
this effect was investigated systematically using ethanol as non-aqueous solvent (n-as),
which is widely utilized in medicine, and DOTATOC as model compound.
Methods: To determine the impact of ethanol on the radiolabeling efficacy, “standard”
labeling conditions of 68Ga-DOTATOC (95–100 °C, 10–15 min, 20–50 μg DOTATOC,
aqueous solution), i.e. 10 nmol (2.9 μM, 14.2 μg), were modified in terms of lower
temperature (70 °C) to achieve lower RCY (<75 %). From those lower RCY, positive
effects of increasing amounts of ethanol (0–40 vol%) could directly be observed.
Labeling parameters were finally evaluated in terms of shorter reaction time and lower
amount of precursor. To investigate whether the effects observed are also true for
other trivalent radiometals, labeling was also performed with 44Sc.
Results: For increasing amounts of ethanol, 68Ga-DOTATOC RCY at 70 °C improved
significantly. RCY of ~95 % can be achieved within 10 min using 30 vol% ethanol
compared to 46 % in the pure aqueous system. If “standard” temperatures of 95 °C are
applied, high RCY of 89 % can be achieved within 5 min with much lower amounts of
precursor, i.e. even at 0.93 nmol (0.3 μM, 1.3 μg). This also represents significantly
increased specific activities. Similar behavior was observed for 44Sc where RCY increase
successively with increasing amounts of ethanol.
Conclusion: There is clear experimental evidence, that adding more than 20 vol%
ethanol to the reaction mixtures significantly improve labeling efficacies. This could be
demonstrated for 68Ga-DOTATOC and 44Sc-DOTATOC in terms of temperature, time
and concentration of required precursor. Whether this is a principal phenomenon with
practical impact on the radiopharmaceutical chemistry of trivalent metals and whether
this applies to other non-aqueous solvents as well - and what the physico-chemical
reasons are, remains to be studied in more detail. Nevertheless, the effect observed
here will improve 68Ga-DOTATOC labeling and may save at least half of the usually
applied amount of precursor.
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Metallic radionuclides represent very important tools in nuclear medicine – both in
non-invasive molecular imaging (SPECT, PET) and for radiotherapy; cf. the systematic
use of e.g. 111In for SPECT, 68Ga for PET, 90Y and several lanthanide radioisotopes for
therapy. Compared to radiopharmaceutical synthesis with non-metallic radionuclides
such as e.g. 11C, 18F and other halogens, synthesis with radiometals are in most cases
easier to perform and may approach kit-type protocols - as well known for 99mTc, the
“working horse” of nuclear medicine.
An essential part of the design of a metal-based radiopharmaceutical is the complex
formation of the radioactive metal ion by ligand (or “chelate”) L. For many trivalent
metals M3+, macrocyclic ligands, especially DOTA, show formidable thermodynamic
stability, which is promising in terms of the kinetic stability of the M3+-L complexes
once formed. This is in particular relevant in the context of molecular imaging of
metal-ligand based radiopharmaceuticals to guarantee stability in vivo. However, in
many cases formation rates of the M3+-L complexes are slow at ambient conditions.
Slow formation rates are, for example, synonym to long radiolabeling protocols, to
increased temperature and/or to relatively high ligand concentration. This may limit
the practical use of e.g. DOTA-based radiopharmaceuticals, in particular of those
labeled with short-living radionuclides like 68Ga (half-life t1/2 = 67.71 min).
Common tools to improve the efficiency of complex formation, are increased
temperature (Cooper et al. 2006; De León-Rodríguez and Kovacs 2008), microwave-
assisted synthesis (Pruszyński et al. 2012) or a significant excess of ligand L concentration.
For example, increased temperature is commonly used to label peptidic DOTA-
conjugated derivatives or DOTA-affibodies with 111In, 90Y or 177Lu approaching quantita-
tive labeling efficiency at sufficient concentration of the DOTA-component (Wild et al.
2003; Laznicek et al. 2002).
Radiochemical M3+-L complex formation yields, in most cases, can be increased by
providing a high concentration of the ligand. For short-lived radiometals, this concen-
tration typically is at micromolar level. Depending on the kind of diagnostic or thera-
peutic application, however, a high specific activity of the radiopharmaceutical is
preferred. For example, receptor imaging and tumor therapy require high specific
activity or low concentration of the peptide, due to the limited number and affinity
of transmembrane tumor receptors. Specific activity is, in this context, often given
as the ratio of product radioactivity and the amount of the e.g. DOTA-precursor
used. It can be significantly affected by non-radioactive metal ion contaminants
competing with the desired radiometal for the ligands. These impurities are present
in the radiometal stock solution, in the used chemicals and glassware. They are
not necessarily reducible and result in a need for higher amounts of required
precursor.
Metal-based radiopharmaceuticals are typically synthesized in aqueous solutions,
where the metal ions are surrounded by strong hydration spheres. Highly charged
metal ions such as Ga3+, Sc3+ and Ln3+ have well-defined first and second hydration
shells (Lindqvist-Reis 2000). In part and among other factors, it is the power of these
hydration shells, which prevents a more direct interaction of the metal cation with the
donor atom of the ligand structures. It had been demonstrated a long time ago that
non-aqueous solvents (e.g. isopropanol) can break up the hydrogen bond between the
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breaker (Idrissi and Longelin 2003). This disorder of the hydration shell in combination
with preferential solvation affects the reactivity of all participants of the reaction
(Pèrez-Malo Cruz and Rösch 2013; Helm and Merbach 2005; Rode et al. 2005), and in
particular induces shifts in the ligands pKa values.
It was shown previously, that this effect may in particular lead to an increased
efficiency of radiometal-ligand complex formation (Usacheva et al. 2012). Accordingly,
a well-designed addition of a certain non-aqueous solvent to a typical aqueous solution
might interestingly be used to reduce (a) reaction time, (b) temperature or (c) amount
of required precursor of M3+-L type radiolabeling reactions.
The most attractive non-aqueous solvent in the context of medical application and
radiopharmaceutical synthesis is ethanol. It is commonly used as additive and solvent
in medical applications to increase the solubility of pharmaceuticals and to act as a pre-
servative. In radiopharmaceutical chemistry, ethanol is known to inhibit ionization-
induced radiolysis. As a result of these qualities, ethanol was already selected as solvent
for post-processing of 68Ge/68Ga generator eluates (Eppard et al. 2014). The present
report describes the effect of an extra addition of ethanol on the complex formation of
68Ga and 44Sc -based radiopharmaceuticals, utilizing DOTA-D-Phe1-Tyr3-octreotide
(DOTATOC) as model compound.
The vision would be to see, whether a certain mixture of ethanol and the aque-
ous solution in the radiolabeling system would a) increase the labeling kinetics,
b) lower the temperature required to achieve a given yield, and c) lower the
amount of the ligand needed to achieve the maximum radiolabeling yields under
fixed conditions. Altogether, these three effects may provide improved yields of a
radiopharmaceutical like e.g. 68Ga-DOTATOC, currently one of the most applied
DOTA-peptides for quantitative molecular imaging of neuroendocrine tumors by
means of PET.Methods
Experimental concept
DOTATOC was used as model compounds due to its prevalent role as therapeutic
(90Y/177Lu-DOTATOC) and also diagnostic (68Ga-DOTATOC and 44Sc-DOTATOC
(Pruszyński et al. 2012)) agent for neuroendocrine tumors (NET). “Standard” 68Ga-
DOTATOC labeling is defined here by heating a pure aqueous buffer solution con-
taining 20–50 μg DOTATOC at 95–100 °C for 10–20 min, yielding relatively high
labeling yields of >95 %. In order to demonstrate the impact of ethanol on radiolabeling
efficacy, those standard labeling conditions of 68Ga-DOTATOC were modified towards
lower (~50 %) radiolabeling yield, which is obtained at lower temperature (70 °C). Indeed,
this labeling profile was taken as a baseline for pure aqueous systems at 10 nmol
(2.93 μM, 14.2 μg) of DOTATOC (Fig. 1). Here, 68Ga-DOTATOC yields are e.g. ~20 % at
5 min, ~45 % at 10 min and ~60 % at 15 min. Then, any increase of labeling yields
induced by the addition of any concentration of ethanol can be determined directly at a
statistically significant level. To investigate if ethanol effects only radiolabeling using 68Ga
or also labeling with other trivalent radiometals, same experimental set-up was adopted
for labeling of DOTATOC with 44Sc in pure aqueous solution.
Fig. 1 Baseline labeling kinetics of 68Ga-DOTATOC in pure aqueous solution at 70 and 95 °C (10 nmol/2.93 μM/
14.2 μg DOTATOC, 15 min, n = 5)
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DOTA-D-Phe1-Tyr3-octreotide (DOTATOC) was obtained from ABX (Radeberg,
Germany) and an aqueous stock solution of 1 mg/mL was prepared. All chemicals were
of pure chemical grade and solvents for HPLC were obtained as HPLC grade. TraceSe-
lect water (Sigma-Aldrich, Germany) was used in all experiments. Labeling reactions
were incubated in a ThermoMixer MHR 11 (DITABIS, Digital Biomedical Imaging
Systems AG).
Activity counting was determined using a borehole counter (Nuklear-Medizintechnik
Dresden GmbH, Germany). RadioTLC was performed using aluminum-backed silica
gel (silica-gel 60 F254; Merck, Darmstadt, Germany) and analyzed using a flatbed-
scanner (Instant Imager®, Packard Canberra, Schwadorf, Austria). HPLC was performed
using Hitachi L-7100 pump system coupled with UV (Hitachi L-7400) and radiometric
(Gaby Star, Raytest Isotopenmessgeräte, GmbH, Straubenhardt, Germany) detectors.Labeling with 68Ga
68Ga obtained from a 1.100 MBq 68Ge/68Ga generator (Eckert & Ziegler Strahlen- und
Medizintechnik AG, Berlin, Germany) with TiO2 matrix, was eluted with 5 mL 0.1 N
HCl and post-processed following a literature procedure (Zhernosekov et al. 2007).
Labeling of DOTATOC was performed by adding the acetone post-processed 68Ga
eluate (400 μL) to a solution of DOTATOC (10 nmoL; 2.93 μM, 14.2 μg) in 3 mL
water containing 0–40 vol% ethanol. The reaction mixture was stirred at 70 °C and
aliquots were taken at 1, 3, 5, 10 and 15 min to analyze radiolabeling kinetics.
All experiments were performed on a laboratory scale and repeated three times (n = 3).
In order to compare the labeling yields of the standard labeling protocol at 95 °C with
and without ethanol content, the effect of ethanol addition (40 vol%) on labeling yields
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0.0043–44.1 μg).Labeling with 68Ga on a module system
Finally, experiments with 68Ga-DOTATOC were performed in addition using a module
system to evaluate the impact of ethanol on labeling efficacy with regard to routine
tracer production (Eckert & Ziegler, Modular Lab Eazy).
68Ga obtained from a 1.100 MBq 68Ge/68Ga generator (Eckert & Ziegler Strahlen- und
Medizintechnik AG, Berlin, Germany) with TiO2 matrix, was eluted with 0.1 N HCl and
post-processed with ethanol/HCl solution according literature (Eppard et al. 2014;
Zhernosekov et al. 2007). In order to achieve a 40 vol% ethanol/water mixture, there are
two options, which is either offline or online. Offline means the preparation of the mix-
ture by dissolving the needed amount of DOTATOC in water or aqueous buffer and sub-
sequent adding 40 vol% of ethanol. To this mixture the purified fraction of 68Ga is added
before heating. In contrast, online corresponds to the preparation of the “standard” aque-
ous solution containing DOTATOC, while the post-processed 68Ga added already
contains the needed amount of ethanol. This is achieved by purifying 68Ga eluates from
68Ge generators utilizing a modified version of the cation exchange-based post-processing
introduced in 2007 (Zhernosekov et al. 2007) according to a recently published variant
based on ethanol/HCl mixtures to desorb 68Ga from the cation exchanger resin (Eppard
et al. 2014).
Labeling of DOTATOC was performed on a radiosynthesis system (Modular-Lab
eazy, Eckert & Ziegler Strahlen- und Medizintechnik AG, Berlin, Germany) and con-
stant reaction time (480 s) by adding aliquots of DOTATOC stock solution (1 mg/mL)
to mixtures of post-processed 68Ga eluate (1 mL) and 1 M NH4OAc solution (900 μL)
which corresponds to an ethanol content of 47 vol%. The concentration of DOTATOC
was varied between 7.0 nmol (3.67 μM, 10 μg) and 28.1 nmol (14.56 μM, 40 μg) with
constant temperature (110 °C as defined by the module).Labeling with 44Sc
44Sc was eluted from a 180 MBq 44Ti/44Sc generator using a 0.005 M H2C2O4/0.07 M
HCl solution (Filosofov et al. 2010) and post-processed as previously described
(Pruszyński et al. 2012). The purified aqueous eluate was used for further labeling
studies with DOTATOC (20 nmol, 6.60 μM, 28.4 μg) and varying ethanol content
(0–40 vol%). The reaction mixture was stirred at 70 °C for 30 min and aliquots
were taken at 1, 3, 5, 10, 20 and 30 min to analyze radiochemical yields.Quality control
RadioTLC was used to analyze the reaction yields. Aliquots of each reaction solu-
tion were spotted on TLC-plates, developed with 0.1 M sodium citrate solution
(pH 4.0) and analyzed using a flatbed-scanner. Additionally, radiochemical purity
was analyzed using radioHPLC with a LiChrosphere 100 RP-18 EC column (5 μm,
250 × 4 mm). The gradient elution system utilized mobile phase A (water + 0.01 %
TFA) and mobile phase B (acetonitrile + 0.01 % TFA). A flow rate of 0.8 mL/min
was used, starting with 82 % A for 2 min; then the gradient was increased to 30 %
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parameters returned to the initial conditions during 12 min.Results
68Ga-DOTATOC: Labeling yields
The effect of adding ethanol was first investigated for radiolabeling DOTATOC, using
10 nmol (2.93 μM) DOTATOC, at 70°. Indeed, this labeling profile was taken as a
reference for pure aqueous systems at 10 nmol (2.93 μM, 14.2 μg) of DOTATOC
(Fig. 1). Then, any effect on labeling yields induced by the addition of any concentration
of ethanol can be determined directly at a statistically significant level.
While addition of 10 vol% ethanol after 15 min leads to a small but highly
reproducible increase by factor of 1.2, a further increase of the ethanol content up
to 40 vol% results in labeling yields of approximately 95 % within 15 min, which is
an increase by a factor of 1.5 at 70 °C for DOTATOC. These impressive effects are
illustrated in Fig. 2 for the labelling yields for the 4 different concentrations of
ethanol. The relative increase of 68Ga-DOTATOC labeling yields in the ethanol
system (relative to pure aqueous solution) observed at 15 min reaction time is 1.2
(10 vol%), 1.4 (20 vol%), 1.5 (30 vol%) and 1.5 (40 vol%) at 70 °C.68Ga-DOTATOC: Labeling kinetics
Interestingly, the effect is even more pronounced at shorter reaction times. Figure 3
illustrates this effect.
The observed relative increase at e.g. 5 min is 3.6 for 40 vol% (at 70 °C). Table 1 gives
the relative increase of the yields for 5, 10 and 15 min reaction period for 10–40 vol%
of ethanol compared to the pure aqueous system.Fig. 2 Labeling kinetics of 68Ga-DOTATOC in presence of 0–40 vol% ethanol (10 nmol/2.93 μM/14.2 μg
DOTATOC, 70 °C, n = 3)
Fig. 3 Increase of labeling yield of 68Ga-DOTATOC depending on the individual amounts of additional ethanol
(10 nmol/2.93 μM/14.2 μg DOTATOC, 70 °C, n = 3)
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With the dramatic increase in reaction yields in ethanol containing solvent mixtures,
in particular at shorter reaction periods, one may stipulate, that 68Ga-DOTATOC la-
beling is more effective with lower amounts of DOTATOC in ethanol/water mixtures
compared to the standard aqueous system (with “standard” here again referring to
pure aqueous solutions and reaction temperatures of 95 °C). Consequently, the de-
pendence of the radiochemical yield on the concentration of DOTATOC in presence
of 40 vol% ethanol was investigated and compared to identical non-ethanol systems
for synthesis temperatures of 95 °C. The reaction time was 5 min in both cases.
Figure 4 shows the effect of 40 vol% ethanol in the reaction mixture on labeling
yields with the DOTATOC precursor amount varied from 0.003 to 31 nmol
(0.001–10 μM). For high amounts such as 31 nmol (10 μM) DOTATOC, the radio-
chemical yields are similar (96.3 %/97 %) for the pure aqueous and the ethanol/water
system. However, in the pure aqueous system the radiochemical yields drop with
decreasing amount of DOTATOC, reaching values of 90.7 ± 2.2 %, 87.7 ± 0.3 % and
57.5 ± 0.3 % at 9.3 nmol (3 μM), 3.1 nmol (1 μM) and 0.9 nmol (0.3 μM) DOTATOC,
respectively. In contrast, the presence of 40 vol% ethanol keeps 68Ga-DOTATOC
labeling still efficient with labeling yields of 95.6 ± 0.9 %, 95.4 ± 0.6 % and 88.7 ± 0.2 %Table 1 Increase of 68Ga-DOTATOC labeling yields depending on the reaction period by factor.
The dramatic increase for short reaction periods such as e.g. 5 min is highlighted in grey
Time [min] Amount of ethanol in the reaction mixture [vol%]
0 10 20 30 40
3 1 1.3 2.0 3.9 5.1
5 1 1.3 1.9 3.1 3.6
10 1 1.2 1.6 1.9 2.0
15 1 1.2 1.4 1.5 1.5
Fig. 4 Dependence of the radiochemical yield of 68Ga-DOTATOC on the concentration of DOTATOC in
presence of 40 vol% ethanol (0.003–31 nmol/0.001–10 μM/0.0043–44.1 μg DOTATOC, 95 °C, 5 min, n = 3)
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TOC thus guarantee 68Ga-DOTATOC yields of >95 %, meeting the requirement of
the European Pharmacopoeia on the product purity of 68Ga-DOTATOC for i.v.
injections. In pure aqueous systems, this >95 % level is achieved at one order of
magnitude higher concentration of DOTATOC only.
A significant effect of ethanol on labeling efficacies occurs in solutions with con-
centrations between 0.03 and 3 μM. The highest increase can be observed at
0.1 μM (0.3 nmol) DOTATOC, where labeling yields are larger by a factor of 2.2
in the ethanol/water system.68Ga-DOTATOC: Specific activity
The radiolabeling yields > 95 % with only 1 μM DOTATOC solutions obtained in
40 vol% ethanol mixtures after 5 min instead of 10 μM in aqueous “standard” systems
are also of practical interest. Compared to the pure aqueous system, the same labeling
yields are achieved at a 10fold lower concentration of DOTATOC. This directly
increases the specific activity of 68Ga-DOTATOC (i.e. the radioactivity of 68Ga relative
to the amount of the DOTATOC) by a factor of 10.68Ga-DOTATOC: Labeling on an automated module
Once the effect of adding ethanol to the reaction mixtures for 68Ga-DOTATOC was
demonstrated at laboratory scale, the next challenge was to transfer this successful
method to automated synthesis modules. To facilitate the daily work with 68Ga, but
also 177Lu and 90Y, Eckert & Ziegler has developed a radiosynthesis system which was
used in this study. The cassette based synthesizer works with a technology which uses
pressure differences to transfer the liquids between the reaction vessels and pre-
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radiochemical purity as well as a short synthesis time.
The amount of ethanol in the reaction mixture accounts to 42 vol% under the condi-
tions used. An amount of precursor of up to 30 μg (21 nmol, 0.01 μM) leads to radiola-
beling yields > 95 %. Even with low amounts of precursor (20 μg, 14 nmol, 0.007 μM)
radiolabeling yields > 90 % can be obtained. It should be noted, that 68Ga-DOTATOC
labeling protocols supplied by most of the commercial manufacturers recommend the
use of more than 30 μg (21 nmol, 0.01 μM) of DOTATOC Fig. 5.44Sc-DOTATOC: Labeling yields
With these dramatic effects observed for 68Ga-DOTATOC, a logic question was to
verify whether the effect observed is specific for the 68Ga-radiocation, or whether it
applies to other trivalent metals used in nuclear medicine as well. Therefore DOTA-
TOC was labeled with the generator-derived positron emitter 44Sc. In the case of
44Sc, high labeling yields of 44Sc-DOTATOC in pure aqueous systems containing
ammonium acetate buffer have been described earlier for 95 °C temperature, but
somewhat extended reaction periods compared to 68Ga-DOTATOC (Pruszyński
et al. 2012).
Indeed, a similar behavior was observed for 44Sc-DOTATOC. Radiochemical yields
increase successively with increasing amounts of ethanol but not that rapidly like for
68Ga-DOTATOC. At 40 vol% of ethanol, labeling yields are more than double (by factor
2.2) after 20 and 30 min (Fig. 6). Under the same conditions of 70 °C and 30 min, yields
of > 90 % can be obtained using 40 vol% ethanol compared to 40.7 ± 3.9 % in the ethanol-
free system. Also similar to 68Ga-DOTATOC, the relative increase is even more
pronounced for short reaction periods (Pruszyński et al. 2012; Flowers L et al. 2003).Fig. 5 Radiochemical purity of 68Ga-DOTATOC depending on the amount of precursor using the automated
labeling module ModularLab eazy (t = 480 s, T = 110 °C, 900 μL NH4OAc buffer pH 7, 1 ml N5, n = 3)
Fig. 6 Labeling kinetics of 44Sc-DOTATOC in presence of 10–40 vol% ethanol compared to the pure aqueous
solution containing ammonium acetate (AmAc) as buffer (20 nmol/6.62 μM/28.5 μg DOTATOC, 70 °C, n = 3)
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The influence of a solvent on solvation and complex formation equilibria of stable
metal ions and ligands is a known phenomenon (Helm and Merbach 2005). For
example, preferential solvation may occur when the solution is a mixture of two or
more solvents, and effects the reactivity of all participants specifically (Helm and
Merbach 2005; Rode et al. 2005; Usacheva et al. 2012). This phenomenon, however,
was never applied in radiopharmaceutical synthesis to economize effectively metal-
based radiolabeling. The results shown here for labeling of DOTATOC with the triva-
lent positron emitters 68Ga and 44Sc are dramatic. The phenomenon is of interest
from a “pure” scientific point of view as it appears to be much more pronounced than
in conventional, e.g. non-radio-chemistry. In parallel, it may be relevant to the routine
synthesis of radiopharmaceuticals based on these metallic radionuclides. The main
features are summarized using 68Ga-DOTATOC as a proof-of-principle PET-
radiopharmaceutical. There are at least 5 basic factors to discuss.Radiochemical labeling yields
For a given reaction system and temperature, the addition of ethanol increases the
radiochemical labeling yields depending on the vol% of the non-aqueous solvent and
the reaction period. For example, after 3 min the increases are as much as 130–500 %
(or factors of >1.3–5) compared to yields achieved with the ethanol-free, pure
aqueous system. At 40 vol% the effect appears to approach saturation.Reaction kinetics
For a given reaction system and temperature, ethanol facilitates the reaction kinet-
ics. Depending on the vol% of the non-aqueous solvent, similar yields, compared
Eppard et al. EJNMMI Radiopharmacy and Chemistry  (2016) 1:6 Page 11 of 13to the ethanol-free system, are obtained faster by factors of >2 or even >5. This is
in particular relevant for short-living radionuclides such as 68Ga.Amount of precursor
For a given reaction system, temperature and period, the addition of ethanol increases
the reaction yields for identical amounts of precursor (e.g. DOTATOC). Depending
on the vol% of the non-aqueous solvent, it can reduce the amount of DOTATOC
needed to e.g. achieve radiochemical yields > 95 % by a factor of 10 or more. This is
synonym to an increase of the 68Ga-DOTATOC product specific activity by a factor
of 10 or more, which is relevant especially in context of receptor imaging and
therapy.Duration of synthesis
Applying optimum reaction conditions, one might guarantee 68Ga-DOTATOC constant
labeling yields > 98 % in routine synthesis. This is well above the current recommenda-
tion of a monograph of the European Pharmacopoeia (European pharmacopoeia 2013).
In this case, radiochemical purification procedures are not needed anymore. In prac-
tice, the duration of the synthesis from elution of the generator until formulation of
the final product will be reduced due to deletion of the purification step. Effectively,
this also contributes to an increase in final product activity. In particular this is rele-
vant for short-living radionuclides such as 68Ga: saving 10 min of reaction time saves
almost 11 % of radioactivity – i.e. increases the final product activity of e.g. 68Ga-
DOTATOC by 11 %.Automated modules
This method based on ethanol/HCl mixtures 68Ga is adsorbed from the initial gener-
ator eluate online, and subsequently releases the purified 68Ga, using solutions in
which the acetone from the original cation exchange post-processing is replaced by
ethanol. The post-processing includes a washing step using 1 mL 80 % EtOH/0.15 M
HCl and the elution step using 1 mL 90 % EtOH/0.9 M HCl. The steps involved are
very similar to those of the acetone-based method, which has been successfully incor-
porated into EZAG® modules. The method is very effective with regard to the removal
of radiochemical (68Ge) and chemical (Fe, Ti) impurities which perturb radiolabeling.
The processed 68Ga eluate facilitates high labeling yields and specific activities due to
the increased chemical and radiochemical purity. In contrast to the acetone-based
protocol, the purified eluate resulting from the ethanol method is more acidic and
needs buffer formulation for radiolabeling. The positive effect of ethanol on radiola-
beling yields can be implemented easily on automated module systems taking the
advantage of ethanol-based cation-exchange post-processing. Legal requirements can
already be fulfilled without purification using 30 μg (21 nmol, 0.01 μM) precursor,
which results in reduced duration of synthesis and higher specific activity. This is sig-
nificantly lowered compared to the amount recommended by commercial suppliers
for reliable synthesis on automated modules.
In the present study, the experimental effects of adding various amounts of
ethanol to the “standard” aqueous solutions in the preparation of 68Ga-DOTATOC
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increase of the efficacy of 68Ga-DOTATOC labeling reactions. It concerns three ex-
perimental parameters rather directly, namely (1) labeling yields, which increase
compared to yields in the ethanol-free, pure aqueous system, (2) labeling kinetics,
which are faster and (3) amounts of DOTATOC precursor needed, which are less by
at least an order of magnitude. Altogether, it (4) allows robust and reliable 68Ga-
DOTATOC batch purities of > 95 % as determined both by radioTLC and radioHPLC.
There was no evidence of any colloid formation in the ethanol-containing solution
even when aiming high specific activities. However, there are even four more
effects, which result from the ones mentioned. One is the significant increase in
specific activity of 68Ga-DOTATOC preparations as a consequence of (3).
A further effect is on lyophilized kit-type samples of DOTATOC which may be
used, where the adequate vol% of ethanol is added immediately prior to the addition
of the purified 68Ga generator eluate. This may further stimulate the development of
kit-type formulations of 68Ga radiopharmaceuticals. In the case of 68Ga-DOTATOC,
the high labeling yield of > 95 % makes purification steps obsolete, and the formula-
tion just diluted with saline followed by sterile filtration is ready for application. This
would make 68Ga-DOTATOC synthesis approaching the ease of 99mTc-kit prepara-
tions. Moreover, those reaction protocols are easily to adopt on automated or semi-
automated modules available for radiometal-based synthesis. The increased yield at
shorter reaction periods and the avoiding of any additional purification step may
cumulatively save 10 min or more until the 68Ga-DOTATOC batch is ready for injec-
tion. This increases the real 68Ga-DOTATOC activity available by about 10 % or
more. Finally, there is another effect of rather economic value: an institution routinely
performing 68Ga-DOTATOC PET for neuroendocrine tumors may, depending on
the frequency of batch synthesis, need e.g. 100 μg of DOTATOC each day. Within
100 working days, which maybe is the shelf-life of a 68Ge/68Ga generator, this
accumulates to 10 mg. Nevertheless, with saving the amount of DOTATOC, there
comes a significant economic impact.
Conclusion
The authors hypothesize, that this may constitute a fundamental aspect in radio-
pharmacy. The effects shown for 68Ga-DOTATOC are not unique for this particu-
lar radiopharmaceutical. It holds true for 44Sc also, and underlines the assumption,
that the effect achieved by adding ethanol to pure aqueous reaction mixtures facili-
tates complex formation in many directions in general: Mixtures of aqueous and
ethanol significantly improve labeling efficacies of metal-based radiopharmaceuticals
e.g. 68Ga-DOTATOC in terms of temperature, time and concentration of required
precursor (Pèrez-Malo Cruz and Rösch 2013).
However, it’s scientific rational and its applicability to various radiometals of
varying valence states requires much more and systematic investigation, which are
currently performed. Simultaneously, the physico-chemical nature of the impact of
ethanol/water mixtures or mixtures using other non-aqueous solvents on the
radiometal-ligand complex formation deserves further scientific investigation. This
is beyond the scope of the present study, which intends to highlight the practical
impact for radiopharmaceutical chemistry only. Those studies are ongoing.
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